LIMN insider transaction filings

Liminatus Pharma, Inc. — 2 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-14. Screen LIMN transaction legs live →

Insider transaction summary — last 90 days

2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Valetudo Therapeutics LLC — 10% owner & Kim Chris — Chief Executive Officer, Director, 10% owner22

Recent Form 4 filings — Liminatus Pharma, Inc.

FiledFormInsiderReported transactionsSource
2026-07-144Valetudo Therapeutics LLC — 10% owner
Kim Chris — Chief Executive Officer, Director, 10% owner
Other (J): 3,448,926EDGAR
2026-07-064Valetudo Therapeutics LLC — 10% owner
Kim Chris — Chief Executive Officer, Director, 10% owner
Other (J): 4,373,603EDGAR

Recent 8-K events — Liminatus Pharma, Inc.

FiledFormItems reportedSource
2026-08-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-07-308-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-248-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-068-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.02 — Unregistered Sales of Equity Securities
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-038-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-278-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-048-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-188-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=LIMN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →